17-73236243-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001351264.2(C17orf80):c.761G>A(p.Gly254Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001351264.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C17orf80 | NM_001351264.2 | c.761G>A | p.Gly254Asp | missense_variant | 3/6 | ENST00000535032.7 | NP_001338193.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C17orf80 | ENST00000535032.7 | c.761G>A | p.Gly254Asp | missense_variant | 3/6 | 1 | NM_001351264.2 | ENSP00000440551 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 28AN: 251106Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135834
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461870Hom.: 0 Cov.: 37 AF XY: 0.0000646 AC XY: 47AN XY: 727234
GnomAD4 genome AF: 0.000118 AC: 18AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.761G>A (p.G254D) alteration is located in exon 3 (coding exon 1) of the C17orf80 gene. This alteration results from a G to A substitution at nucleotide position 761, causing the glycine (G) at amino acid position 254 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at